In their bid to find the best combination of therapies to treat anaplastic thyroid cancer (ATC), researchers on Mayo Clinic's Florida campus demonstrated that all histone deacetylase (HDAC) inhibitors are not created equal.
Jul 23, 2015
0
8
Cancer researchers at Mayo Clinic's campus in Jacksonville, Florida, have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC)—a lethal tumor with no effective therapies. The molecule ...
Feb 17, 2015
0
10
The DNA of a woman whose lethal thyroid cancer unexpectedly "melted away" for 18 months has revealed new mechanisms of cancer response and resistance to the drug everolimus, said researchers from Dana-Farber Cancer Institute ...
Oct 8, 2014
0
0
Incidence of thyroid cancer is rising faster in Pennsylvania than in the rest of the United States, according to Penn State College of Medicine researchers.
Sep 10, 2014
2
0
(Medical Xpress)—A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial, say researchers at Mayo Clinic in Florida.
Apr 19, 2013
0
0
A molecule widely believed to fight many forms of cancer actually helps deadly thyroid tumors grow, and cancer therapies now being tested in humans might boost the activity of this newly revealed bad guy, researchers at Mayo ...
Jun 20, 2012
0
0
